The Irish pharmaceutical industry over the boom period and beyond
暂无分享,去创建一个
[1] Cyprus. Tmēma Statistikēs kai Ereunōn. Census of industrial production , 1983 .
[2] J. Howells. The location of research and development: Some observations and evidence from Britain , 1984 .
[3] W. Diebold,et al. The Second Industrial Divide , 1985 .
[4] N. Hood,et al. Global Strategies, Multinational Subsidiary Roles and Economic Impact in Scotland , 1988 .
[5] J. Stewart. Transfer Pricing: Some Empirical Evidence from Ireland , 1989 .
[6] C. Bartlett,et al. Managing the Global Firm , 1990 .
[7] J. Howells. Pharmaceuticals and Europe 1992: The Dynamics of Industrial Change , 1992 .
[8] Nicholas A. Phelps,et al. Contemporary Industrial Restructuring and Linkage Change in an Older Industrial Region: Examples from the Northeast of England , 1993 .
[9] I. Turok. Inward Investment and Local Linkages: How Deeply Embedded is “Silicon Glen”? , 1993 .
[10] James Taggart,et al. The World Pharmaceutical Industry , 1993 .
[11] G. Gereffi,et al. Commodity Chains and Global Capitalism , 1994 .
[12] R. Hudson. New Production Concepts, New Production Geographies? Reflections on Changes in the Automobile Industry , 1994 .
[13] N. Hood,et al. Multinational Enterprises and Regional Economic Development , 1994 .
[14] J. Fitzgerald,et al. The Manufacturing Sector , 1996 .
[15] David Bradley,et al. Regional Incentives and the Quality of Mobile Investment in the Less Favoured Regions of the EC , 1996 .
[16] B. Berry,et al. The Global Economy in Transition , 1996 .
[17] V. Chiesa. Separating research from development: Evidence from the pharmaceutical industry , 1996 .
[18] E. Malecki. Technology and Economic Development: The Dynamics of Local, Regional and National Competitiveness , 1997 .
[19] M. Alpers,et al. Research and Development , 1960, Nature.
[20] R. Hudson. Regional Futures: Industrial Restructuring, New High Volume Production Concepts and Spatial Development Strategies in the New Europe , 1997 .
[21] S. Schweitzer. Pharmaceutical Economics and Policy , 1997 .
[22] T. K. Hazlet. Pharmaceutical Economics and Policy , 1998 .
[23] A. Pike,et al. Making Performance Plants from Branch Plants? In Situ Restructuring in the Automobile Industry in the United Kingdom , 1998 .
[24] D. Sadler,et al. The global economy in transition , 1998 .
[25] M. Agrawal. Global Competitiveness in the Pharmaceutical Industry: The Effect of National Regulatory, Economic, and Market Factors , 1999 .
[26] G. Reger. Internationalization of Research and Development in Pharmaceuticals , 2000 .
[27] G. Reger,et al. Dynamics of the Markets and Market Structure , 2000 .
[28] H. Yeung. Book Review: Global transformations: politics, economics and culture , 2000 .
[29] B. Walsh,et al. The Making of the Celtic Tiger: The inside Story of Ireland's Boom Economy , 2000 .
[30] H. Yeung. Organizing ‘the firm’ in industrial geography I: networks, institutions and regional development , 2000 .
[31] G. Gereffi,et al. Local Clusters in Global Chains: The Causes and Consequences of Export Dynamism in Torreon's Blue Jeans Industry , 2001 .
[32] G. Gereffi. Shifting Governance Structures in Global Commodity Chains, With Special Reference to the Internet , 2001 .
[33] K. Olds,et al. Chains and networks, territories and scales: towards a relational framework for analysing the global economy , 2001 .
[34] H. Yeung,et al. Global production networks and the analysis of economic development , 2002 .
[35] C. Bartlett,et al. Managing across Borders , 2003 .
[36] Christian Zeller. North Atlantic Innovative Relations of Swiss Pharmaceuticals and the Proximities with Regional Biotech Arenas , 2004 .
[37] D. Jacobson,et al. The rise and demise of the Irish and Scottish computer hardware industry , 2004 .
[38] Eoin O'Driscoll,et al. Ahead of the curve : Ireland's place in the global economy , 2004 .
[39] Mihir A. Desai,et al. The Demand for Tax Haven Operations , 2005 .
[40] P. Dicken,et al. ‘Globalizing’ regional development: a global production networks perspective , 2004 .
[41] F. Barry. FDI, transfer pricing and the measurement of R&D intensity , 2005 .
[42] P. Cooke. Rational drug design, the knowledge value chain and bioscience megacentres , 2005 .
[43] C. Egeraat. Spatial concentration in the Irish pharmaceutical industry:the role of government intervention and agglomerationeconomies (NIRSA) Working Paper Series. No.28 , 2006 .
[44] C. Egeraat. Spatial Concentration in The Irish Pharmaceutical Industry : The Role of Government Intervention and Agglomeration Economies , 2006 .
[45] P. Dicken,et al. Global Shift: Mapping the Changing Contours of the World Economy (6th ed.). By Peter Dicken , 2007 .
[46] Brendan Bartley,et al. Understanding contemporary Ireland , 2007 .
[47] Chris Van Egeraat,et al. The drivers of transnational subsidiary evolution: the upgrading ofprocess R&D in the Irish pharmaceutical industry (NIRSA) Working Paper Series. No. 38 , 2008 .
[48] F. Barry,et al. The decline of the computer hardware sector: how Ireland adjusted , 2008 .
[49] G. Reger,et al. Changing Innovation in the Pharmaceutical Industry: Globalization And New Ways Of Drug Development , 2010 .
[50] Chris Van Egeraat,et al. The scale and scope of process R&D in the Irish pharmaceutical industry , 2010 .
[51] I. Baeumer,et al. Clinical Trials in Central and Eastern Europe , 2011 .